BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 25576780)

  • 1. Automated external defibrillator rescues among children with diagnosed and treated long QT syndrome.
    Pundi KN; Bos JM; Cannon BC; Ackerman MJ
    Heart Rhythm; 2015 Apr; 12(4):776-81. PubMed ID: 25576780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary Outcomes in Patients With Long QT Syndrome.
    Rohatgi RK; Sugrue A; Bos JM; Cannon BC; Asirvatham SJ; Moir C; Owen HJ; Bos KM; Kruisselbrink T; Ackerman MJ
    J Am Coll Cardiol; 2017 Jul; 70(4):453-462. PubMed ID: 28728690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left cardiac sympathetic denervation in long QT syndrome: analysis of therapeutic nonresponders.
    Bos JM; Bos KM; Johnson JN; Moir C; Ackerman MJ
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):705-11. PubMed ID: 23728945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter defibrillator treatment in long QT syndrome patients: a national study on adherence to international guidelines.
    Sundström E; Jensen SM; Diamant UB; Rydberg A
    Scand Cardiovasc J; 2017 Apr; 51(2):88-94. PubMed ID: 27936942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience.
    Horner JM; Kinoshita M; Webster TL; Haglund CM; Friedman PA; Ackerman MJ
    Heart Rhythm; 2010 Nov; 7(11):1616-22. PubMed ID: 20816872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac transplantation in children and adolescents with long QT syndrome.
    Kelle AM; Bos JM; Etheridge SP; Cannon BC; Bryant RM; Johnson JN; Ackerman MJ
    Heart Rhythm; 2017 Aug; 14(8):1182-1188. PubMed ID: 28416468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up.
    Mönnig G; Köbe J; Löher A; Eckardt L; Wedekind H; Scheld HH; Haverkamp W; Milberg P; Breithardt G; Schulze-Bahr E; Böcker D
    Heart Rhythm; 2005 May; 2(5):497-504. PubMed ID: 15840474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry.
    Schwartz PJ; Spazzolini C; Priori SG; Crotti L; Vicentini A; Landolina M; Gasparini M; Wilde AA; Knops RE; Denjoy I; Toivonen L; Mönnig G; Al-Fayyadh M; Jordaens L; Borggrefe M; Holmgren C; Brugada P; De Roy L; Hohnloser SH; Brink PA
    Circulation; 2010 Sep; 122(13):1272-82. PubMed ID: 20837891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome.
    Schwartz PJ; Priori SG; Cerrone M; Spazzolini C; Odero A; Napolitano C; Bloise R; De Ferrari GM; Klersy C; Moss AJ; Zareba W; Robinson JL; Hall WJ; Brink PA; Toivonen L; Epstein AE; Li C; Hu D
    Circulation; 2004 Apr; 109(15):1826-33. PubMed ID: 15051644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wearable cardioverter defibrillators for patients with long QT syndrome.
    Owen HJ; Bos JM; Ackerman MJ
    Int J Cardiol; 2018 Oct; 268():132-136. PubMed ID: 30041777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and Management of Athletes With Long QT Syndrome.
    Gomez AT; Prutkin JM; Rao AL
    Sports Health; 2016; 8(6):527-535. PubMed ID: 27480102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome.
    Schneider HE; Steinmetz M; Krause U; Kriebel T; Ruschewski W; Paul T
    Clin Res Cardiol; 2013 Jan; 102(1):33-42. PubMed ID: 22821214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prevention with the implantable cardioverter-defibrillator in high-risk long-QT syndrome patients.
    Biton Y; Rosero S; Moss AJ; Goldenberg I; Kutyifa V; McNitt S; Polonsky B; Baman JR; Zareba W
    Europace; 2019 Feb; 21(2):339-346. PubMed ID: 29947754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Left Cardiac Sympathetic Denervation on the Electromechanical Window in Patients with either Type 1 or Type 2 Long QT Syndrome: A Pilot Study.
    Schneider AE; Bos JM; Ackerman MJ
    Congenit Heart Dis; 2016 Sep; 11(5):437-443. PubMed ID: 26887900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The long-term efficacy of left cardiac sympathetic denervation in long QT syndrome].
    Li X; Li CL; Liu YG; Liu JY; Wang JF; Li ZM; Ma DY; Hu D
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jun; 50(6):556-562. PubMed ID: 35705464
    [No Abstract]   [Full Text] [Related]  

  • 16. Implantable cardioverter-defibrillator explantation for overdiagnosed or overtreated congenital long QT syndrome.
    Gaba P; Bos JM; Cannon BC; Cha YM; Friedman PA; Asirvatham SJ; Ackerman MJ
    Heart Rhythm; 2016 Apr; 13(4):879-85. PubMed ID: 26681611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral cardiac sympathetic denervation in patients with congenital long QT syndrome.
    Tobert KE; Bos JM; Moir C; Polites SF; Ackerman MJ
    Heart Rhythm; 2023 Jul; 20(7):1033-1038. PubMed ID: 36934983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analyses of triggers for recurrent cardiac events in 38 patients with symptomatic long QT syndrome].
    Li K; She F; Yang J; Liu YW; He R; Xie Y; Zhou BD; Lyu TT; Xu BH; Liu FL; Liu F; Zhang P
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Feb; 49(2):165-169. PubMed ID: 33611903
    [No Abstract]   [Full Text] [Related]  

  • 19. Intentional nontherapy in long QT syndrome.
    MacIntyre CJ; Rohatgi RK; Sugrue AM; Bos JM; Ackerman MJ
    Heart Rhythm; 2020 Jul; 17(7):1147-1150. PubMed ID: 32105774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management.
    Goldenberg I; Bradley J; Moss A; McNitt S; Polonsky S; Robinson JL; Andrews M; Zareba W;
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):893-901. PubMed ID: 20233272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.